View printer-friendly version

Emergent BioSolutions Appoints Dr. Karen L. Smith as Chief Medical Officer

GAITHERSBURG, Md. , April 21, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Dr. Karen L. Smith , M.D., Ph.D. as chief medical officer with responsibility for leading and further establishing Emergent’s global integrated capability in clinical